Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

Sequential modelling of the effects of mass drug treatments on anopheline-mediated lymphatic filariasis infection in Papua New Guinea.

Singh BK, Bockarie MJ, Gambhir M, Siba PM, Tisch DJ, Kazura J, Michael E.

PLoS One. 2013 Jun 24;8(6):e67004. doi: 10.1371/journal.pone.0067004. Print 2013. Erratum in: PLoS One. 2014;9(1). doi:10.1371/annotation/54fdf4a6-e2ad-4a3d-bbe8-b28b7a3c5b1e.

2.
3.

Lymphatic filariasis in Papua New Guinea: prospects for elimination.

Bockarie MJ, Kazura JW.

Med Microbiol Immunol. 2003 Feb;192(1):9-14. Epub 2002 Oct 15.

PMID:
12592558
4.

Geographic and ecologic heterogeneity in elimination thresholds for the major vector-borne helminthic disease, lymphatic filariasis.

Gambhir M, Bockarie M, Tisch D, Kazura J, Remais J, Spear R, Michael E.

BMC Biol. 2010 Mar 17;8:22. doi: 10.1186/1741-7007-8-22.

5.
6.

The impact of residual infections on Anopheles-transmitted Wuchereria bancrofti after multiple rounds of mass drug administration.

de Souza DK, Ansumana R, Sessay S, Conteh A, Koudou B, Rebollo MP, Koroma J, Boakye DA, Bockarie MJ.

Parasit Vectors. 2015 Sep 24;8:488. doi: 10.1186/s13071-015-1091-z.

7.

Lymphatic filariasis in Papua New Guinea: distribution at district level and impact of mass drug administration, 1980 to 2011.

Graves PM, Makita L, Susapu M, Brady MA, Melrose W, Capuano C, Zhang Z, Dapeng L, Ozaki M, Reeve D, Ichimori K, Kazadi WM, Michna F, Bockarie MJ, Kelly-Hope LA.

Parasit Vectors. 2013 Jan 11;6:7. doi: 10.1186/1756-3305-6-7. Review.

8.

Population genetics of the filarial worm wuchereria bancrofti in a post-treatment region of Papua New Guinea: insights into diversity and life history.

Small ST, Ramesh A, Bun K, Reimer L, Thomsen E, Baea M, Bockarie MJ, Siba P, Kazura JW, Tisch DJ, Zimmerman PA.

PLoS Negl Trop Dis. 2013 Jul 11;7(7):e2308. doi: 10.1371/journal.pntd.0002308. Print 2013.

9.

Insecticidal bed nets and filariasis transmission in Papua New Guinea.

Reimer LJ, Thomsen EK, Tisch DJ, Henry-Halldin CN, Zimmerman PA, Baea ME, Dagoro H, Susapu M, Hetzel MW, Bockarie MJ, Michael E, Siba PM, Kazura JW.

N Engl J Med. 2013 Aug 22;369(8):745-53. doi: 10.1056/NEJMoa1207594.

10.

Randomised community-based trial of annual single-dose diethylcarbamazine with or without ivermectin against Wuchereria bancrofti infection in human beings and mosquitoes.

Bockarie MJ, Alexander ND, Hyun P, Dimber Z, Bockarie F, Ibam E, Alpers MP, Kazura JW.

Lancet. 1998 Jan 17;351(9097):162-8.

PMID:
9449870
11.

Lymphatic filariasis in Papua New Guinea: interdisciplinary research on a national health problem.

Kazura JW, Bockarie MJ.

Trends Parasitol. 2003 Jun;19(6):260-3. Review.

PMID:
12798083
12.

Reduction in acute filariasis morbidity during a mass drug administration trial to eliminate lymphatic filariasis in Papua New Guinea.

Tisch DJ, Alexander ND, Kiniboro B, Dagoro H, Siba PM, Bockarie MJ, Alpers MP, Kazura JW.

PLoS Negl Trop Dis. 2011 Jul;5(7):e1241. doi: 10.1371/journal.pntd.0001241. Epub 2011 Jul 12.

13.

The impact of a filariasis control program on Lihir Island, Papua New Guinea.

Mitjà O, Paru R, Hays R, Griffin L, Laban N, Samson M, Bassat Q.

PLoS Negl Trop Dis. 2011 Aug;5(8):e1286. doi: 10.1371/journal.pntd.0001286. Epub 2011 Aug 23.

14.

Modelling the distribution and transmission intensity of lymphatic filariasis in sub-Saharan Africa prior to scaling up interventions: integrated use of geostatistical and mathematical modelling.

Moraga P, Cano J, Baggaley RF, Gyapong JO, Njenga SM, Nikolay B, Davies E, Rebollo MP, Pullan RL, Bockarie MJ, Hollingsworth TD, Gambhir M, Brooker SJ.

Parasit Vectors. 2015 Oct 24;8:560. doi: 10.1186/s13071-015-1166-x.

15.

Wuchereria bancrofti transmission pattern in southern Mali prior to and following the institution of mass drug administration.

Coulibaly YI, Dembele B, Diallo AA, Kristensen S, Konate S, Dolo H, Dicko I, Sangare MB, Keita F, Boatin BA, Traore AK, Nutman TB, Klion AD, Touré YT, Traore SF.

Parasit Vectors. 2013 Aug 28;6(1):247. doi: 10.1186/1756-3305-6-247.

16.

Vector transmission heterogeneity and the population dynamics and control of lymphatic filariasis.

Michael E, Gambhir M.

Adv Exp Med Biol. 2010;673:13-31. Review.

PMID:
20632527
17.

The impact of mass drug administration and long-lasting insecticidal net distribution on Wuchereria bancrofti infection in humans and mosquitoes: an observational study in northern Uganda.

Ashton RA, Kyabayinze DJ, Opio T, Auma A, Edwards T, Matwale G, Onapa A, Brooker S, Kolaczinski JH.

Parasit Vectors. 2011 Jul 15;4:134. doi: 10.1186/1756-3305-4-134.

18.

Lymphatic filariasis control in Tanzania: effect of six rounds of mass drug administration with ivermectin and albendazole on infection and transmission.

Simonsen PE, Derua YA, Kisinza WN, Magesa SM, Malecela MN, Pedersen EM.

BMC Infect Dis. 2013 Jul 21;13:335. doi: 10.1186/1471-2334-13-335.

19.

Complex ecological dynamics and eradicability of the vector borne macroparasitic disease, lymphatic filariasis.

Gambhir M, Michael E.

PLoS One. 2008 Aug 6;3(8):e2874. doi: 10.1371/journal.pone.0002874.

20.

Mass treatment to eliminate filariasis in Papua New Guinea.

Bockarie MJ, Tisch DJ, Kastens W, Alexander ND, Dimber Z, Bockarie F, Ibam E, Alpers MP, Kazura JW.

N Engl J Med. 2002 Dec 5;347(23):1841-8.

Supplemental Content

Support Center